#USA #New York #Vascular Health #Koya Medical #Dayspring treatment

Koya Medical's Participation at the 2025 Stifel Healthcare Conference

Koya Medical is set to make waves at the Stifel 2025 Healthcare Conference, happening on November 13, 2025, at the Lotte New York Palace Hotel. This event will be an important milestone for Koya as they aim to shed light on their commitment to enhancing vascular health through innovative patient-centered solutions.

Who is Koya Medical?

Founded in 2018 and headquartered in Dallas, Koya Medical is at the forefront of the medtech industry. The company focuses on redefining vascular health with solutions that bridge the gap from medical treatments to home care. After undergoing a personal journey with vascular disease, the founder, Andy Doraiswamy, sought to develop effective, evidence-based treatments that cater to patients’ needs.

Koya’s flagship product, the Dayspring® non-pneumatic compression system, has already gained FDA approval. This device is designed specifically for the treatment of chronic edema, illustrating the company’s dedication to addressing significant health gaps that affect millions.

Key Conference Highlights

During the conference, CEO Andy Doraiswamy will provide insights into Koya's latest clinical research, their strategic growth plans, and the ongoing commercialization of their flagship product, the Dayspring compression system. Attendees will also have the opportunity for one-on-one networking sessions with Koya’s leadership team to dig deeper into their innovative solutions.

The discussion is expected to cover the critical nature of vascular health, particularly as over 35 million Americans suffer from venous and lymphatic diseases. The impact of these conditions can be vast, affecting mobility, quality of life, and long-term health outcomes, emphasizing the urgent necessity for modern and scalable healthcare solutions.

Moving Forward with Innovation

Koya Medical's pipeline doesn’t stop at the Dayspring system; they have a comprehensive array of vascular solutions planned for the continuum of care. This ambitious approach aims to provide a full spectrum of treatments that cater to diverse patient needs, ensuring that care extends beyond the clinic.

The 2025 Healthcare Conference is not just a platform for Koya Medical to promote their products but also serves as a call to action for the medical community to recognize the importance of vascular health advancements. As Koya leads the way with its patient-focused approach, they hope to inspire others in the medtech field to prioritize evidence-based innovation and break down barriers to effective treatment.

Conclusion

Koya Medical is on a mission to close existing treatment gaps in vascular health, and their participation in the Stifel 2025 Healthcare Conference is a crucial part of that journey. With a clear vision and solid leadership, Koya is set to influence the future of vascular health positively and continue championing the needs of patients.

To learn more about Koya Medical and their initiatives, visit their official website at www.koyamedical.com and connect with them on LinkedIn.